Cargando…
Trends in oral anticoagulant choice for acute stroke patients with nonvalvular atrial fibrillation in Japan: The SAMURAI‐NVAF Study
BACKGROUND: Large clinical trials are lack of data on non‐vitamin K antagonist oral anticoagulants for acute stroke patients. AIM: To evaluate the choice of oral anticoagulants at acute hospital discharge in stroke patients with nonvalvular atrial fibrillation and clarify the underlying characterist...
Ejemplares similares
-
Prior Anticoagulation and Short‐ or Long‐Term Clinical Outcomes in Ischemic Stroke or Transient Ischemic Attack Patients With Nonvalvular Atrial Fibrillation
por: Tokunaga, Keisuke, et al.
Publicado: (2019) -
Cost-effectiveness of edoxaban versus rivaroxaban for stroke prevention in patients with nonvalvular atrial fibrillation (NVAF) in the US
por: Miller, Jeffrey D, et al.
Publicado: (2016) -
Clinical outcomes and treatment patterns among Medicare patients with nonvalvular atrial fibrillation (NVAF) and chronic kidney disease
por: Wilson, Lauren E., et al.
Publicado: (2019) -
National Physician Survey for Nonvalvular Atrial Fibrillation (NVAF)
Anticoagulation Comparing Knowledge, Attitudes and Practice of Cardiologist to
PCPs
por: Saeed, Haseeb, et al.
Publicado: (2020) -
Samurai
por: Matsubara, Hisako
Publicado: (1997)